Accelerate Patient Enrollment. Meet Your Deadlines.
Our end-to-end recruitment platform gives CROs and sponsors real-time visibility into enrollment progress while delivering pre-qualified patients to sites. One integrated solution. Complete transparency.
THE CHALLENGE YOU'RE FACING
You're managing multiple trials across dozens of sites. Enrollment is behind on half of them. You're juggling different recruitment vendors with different systems, different logins, different reporting formats.
FDA's new Diversity Action Plan requirements add another layer of complexity. You need representative enrollment—but traditional methods aren't reaching diverse populations.
There's a better way.
5 REASONS PARTNERING WITH US IS A NO-BRAINER
ONE PLATFORM, COMPLETE VISIBILITY
Stop juggling multiple vendor portals.
Our single-sign-on dashboard shows you enrollment progress across all sites, all sources, all metrics—in real time. You always know exactly where you stand.
Result:
Answer sponsor questions immediately with real data—not vendor reports from last week.
WE SEND SITES PATIENTS, NOT LEADS
75% reduction in screen failures.
Other vendors dump unqualified leads on sites. We pre-screen EVERY patient against your protocol before referral. Sites receive only patients who are likely to qualify.
Result:
Happier sites, faster enrollment, lower cost per randomized patient.
94% FASTER ENROLLMENT TIMELINES
Proven acceleration across 200+ trials.
Our platform has demonstrated 94% faster enrollment and 75% reduced startup times. When sponsors ask about your enrollment capabilities, you have data to back up your answer.
Result:
Win more pharma contracts with documented enrollment performance.
DIVERSITY COMPLIANCE BUILT IN
FDA Diversity Action Plan ready.
FDA's diversity requirements are mandatory for pivotal trials. Our bilingual team and diversity-focused campaigns have increased Hispanic enrollment from 12% to 44% on cardiovascular trials.
Result:
Meet diversity requirements without separate vendors or fragmented efforts.
PERFORMANCE-BASED PARTNERSHIP
Our success is tied to your enrollment targets.
We structure partnerships around results, not activity. We don't celebrate high lead volumes with low conversion—we fix them.
Result:
Aligned incentives and shared accountability for enrollment success.
PARTNERSHIP MODELS
Full recruitment management for individual studies. We deploy digital campaigns, pre-screen patients, coordinate with sites, and track enrollment—all visible in your dashboard.
Start with one study. See the results. Then expand.
Dedicated account team, portfolio-level strategy, preferential terms, priority support. One partner for all your patient recruitment needs across all therapeutic areas.
When enrollment is at risk, we move fast. We can launch recruitment within 1-2 weeks (vs. standard 2-3 weeks) with accelerated patient delivery.
Focused engagement of underrepresented populations. Our bilingual team, community partnerships, and targeted campaigns ensure you meet diversity requirements with documentation for regulatory submissions.
IMPLEMENTATION TIMELINE
WE PARTNER WITH
Tier 1 CROs
IQVIA, PPD (Thermo Fisher), Syneos Health, Covance, Medpace, Parexel, ICON
Specialty CROs
Oncology specialists, CNS-focused CROs, rare disease experts
Emerging CROs
Growth-stage organizations building enrollment capabilities
Pharmaceutical Sponsors
Pfizer, Merck, J&J, Novartis, Roche, AstraZeneca, BMS, Eli Lilly, Genentech, Gilead, AbbVie, Amgen
Biotech Companies
Emerging biotech with Phase I-III programs, rare disease developers